Role of tumoral markers in the biological behaviour of solid tumours;Rôle des marqueurs tumoraux dans le comportement biologique des tumeurs

Immuno-Analyse et Biologie Specialisee

Volumn 19, Issue 5 SPEC. ISS., 2004, Pages 241-249

  Pichon, M F ^a  

^a CENTRE RENÉ HUGUENIN   (France)

Author keywords

Adh sion intercellulaire; Angiogenesis; Angiogen se; Cell cycle; Cell mediated immunity; Cycle cellulaire; Immunit antitumorale; Inter cellular adhesion; Marqueurs tumoraux; Tumour markers

Indexed keywords

BIOCHEMICAL MARKER; CELL ADHESION MOLECULE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MUCIN 1; PROTEINASE; TUMOR ANTIGEN; TUMOR MARKER;

ANGIOGENESIS; BASEMENT MEMBRANE; CELL ACTIVITY; CELL ADHESION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; INTRACELLULAR SPACE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MUTATION; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; SOLID TUMOR; STROMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

EID: 4744353877     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2004.07.007     Document Type: Short Survey

References (73)

1. B. Al Mehdi, K. Tozawa, A.B. Fisher, and R.J. Muschel Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis Nat. Med. 6 2000 100 102
2. C. Balague, G. Gamsus, C. Carrato, N. Porchet, J.P. Aubert, and Y.S. Kim AItered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines Gastroenterology 106 1994 1054 1061
3. S.P. Balk, Y.J. Ko, and G.J. Bubley Biology of prostate-specific antigen J. Clin. Oncol. 21 2003 383 391
4. A. Baruch, M.L. Hartmann, S. Zrihan-Licht, S. Greenstein, M. Burstein, and I. Keydar Preferential expression of novel MUC 1 tumor antigen isoform in human epithelial tumors and their tumor-potentiating function Int. J. Cancer 71 1997 741 749
5. A. Baruch, M.L. Hartmann, M. Yoeli, Y. Adereth, Y. Stadler, and Y. Skornik The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein Cancer Res. 59 1999 1552 1561
6. I.R.G. Beavon The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation Eur. J. Cancer 36 2000 1607 1620
7. S. Benchimol, A. Fuks, S. Jothy, N. Beauchemin, K. Shirota, and C.P. Stanners Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule Cell 57 1989 327 334
8. A. Bethune-Volters, and M.F. Pichon Overview of data correlating serum HER2/neu extracellular domain and responses to trastuzumab treatment in HER-2-overexpressing breast cancer Human epidermal growth factors in oncology 1 2003 3 5
9. Bethune-Volters A., Labroquere M., Guepratte S., Hacene K., Neumann R., Carney W., et al. Longitudinal changes in serum HER-2/neu oncoprotein levels in trastuzumab-treated metastatic breast cancer patients. Anticancer Res. 2004; 24, 1083-90.
10. T. Bogenrieder, and M. Herlyn Axis of evil: molecular mechanisms of cancer metastasis Oncogene 22 2003 6524 6536
11. P.C. Brooks Cell adhesion molecules in angiogenesis Cancer Metastasis Rev. 15 1996 187 194
12. A. Cairns, R. Khokha, and R.Pl. Hil Molecular mechanisms of tumor invasion and metastasis: an integrated view Curr. Mol. Med. 3 2003 659 671
13. W.P. Carney, R. Neumann, A. Lipton, K. Leitzel, S. Ali, and C.P. Price Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer Clin. Chem. 49 2003 1579 1598
14. A. Choudhury, N. Moniaux, A.B. Ulrich, B.M. Schmied, J. Standop, and P.M. Pour MUC 4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGF-β2 Br. J. Cancer 90 2004 657 664
15. N. Daémi, T. Vallet, M.F. Acquier, and L. Remy Laminine, intégrines, organisation et comportement invasif des adé nocarcinomes Med. Sci. (Paris) 10 1994 1275 1281
16. E. Danen, and A. Sonnenberg Integrins in regulation of tissue development and function J. Pathol. 200 2003 471 480
17. S. Dedhar Integrin mediated signal transduction in oncogenesis: an overview Cancer Metastasis Rev. 14 1995 165 172
18. K. Dhomoti, S. Hojo, J. Fujita, Y. Yang, H. Ueda, and S. Bandoh The role of caspase 3 in producing cytokeratin 19 fragment (Cyfra 21-1) in human lung cancer cell lines Int. J. Cancer 91 2001 468 473
19. E.P. Diamandis, G.M. Yousef, J. Clements, L.K. Ashworth, S. Yoshida, and T. Egelrud New nomenclature for the human tissue kallikrein gene family Clin. Chem. 46 2000 1855 1858
20. E.P. Diamandis Prostate specific antigen: a cancer fighter and a valuable messenger? Clin. Chem. 46 2000 896 900
21. N.E. Dick Breast cancer stem cells revealed Proc. Natl. Acad. Sci. USA 100 2003 3547 3549
22. S. Eiras, and M.V. Croce Breast cancer associated mucin: a review Allergol. Immunopathol. (Madr.) 5 1997 176 181
23. S.P. Ethier Signal transduction pathways: the molecular basis for targeted therapies Semin Rad Oncol 12 Suppl. 2 2003 3 10
24. G.I. Evan, and K.H. Vousden Proliferation, cell cycle and apoptosis in cancer Nature 411 2001 342 348
25. B. Felding-Habermann, T.E. O'Toole, J.W. Smith, E. Fransvea, Z.M. Ruggeri, and M.H. Ginsberg Integrin activation controls metastasis in human breast cancer Proc. Natl. Acad. Sci. USA 98 2001 1853 1858
26. J.C. Feldner, and B.H. Brandt Cancer cell motility-on the road from c-erbB-2 receptor steered signaling to actin reorganization Exp. Cell Res. 272 2002 93 108
27. A.H. Fortier, B.J. Nelson, D.K. Grella, and J.W. Holaday Antiangiogenic activity of prostate specific antigen J. Natl. Cancer lnst. 91 1999 635 640
28. x and related structures as adhesion molecules Histochem. J. 24 1992 771 776
29. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
30. D. Hanahan, and R.A. Weinberg Hallmarks of Cancer Cell 100 2000 57 70
31. A.L. Harris Angiogenesis as a new target for cancer control Eur. J. Cancer 1 2003 1 12
32. M.L. Hartman, A. Baruch, I. Ron, Y. Aoeret, M. Yoeli, and G. Sagi-Assif MUC 1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel WC1TY protein in breast and ovarian cancer Int. J. Cancer 82 1999 256 267
33. L.H. Hartwell, and M.B. Kastan Cell cycle control and cancer Science 266 1994 1821 1827
34. S. Hirohashi, and Y. Kanai Cell adhesion system and human cancer morphogenesis Cancer Sci. 94 2003 575 581
35. J.J.L. Ho, and Y.S. Kim Serological pancreatic tumor markers and the MUC1 apomucin Pancreas 9 1994 674 691
36. K.V. Honn, and D.G. Tang Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix Cancer Metastasis Rev. 11 1992 353 375
37. J.P. Johnson Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease Cancer Metastasis Rev. 10 1991 11 22
38. H. Jin, and J. Varner Integrins: roles in cancer development and as treatment targets Br. J. Cancer 90 2004 56 565
39. S. Jothy, S.B. Munro, L. LeDuy, D. McClure, and O.W. Blaschuk Adhesion or anti-adhesion in cancer: what matters more? Cancer Metastasis Rev. 14 1995 363 376
40. K. Kaban, and R.S. Herbst Angiogenesis as a target for cancer therapy Hematol. Oncol. Clin. N. Am. 6 2002 1125 1171
41. J.L. Kam, L.H. Regimbald, J.H. Hilgers, P. Hoffman, M.J. Krantz, and B.M. Longenecker MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats Cancer Res. 58 1998 5577 5581
42. Y.S. Kim, J.R. Gum, S.C. Crawley, G. Dengl, and J.J.L. Ho Mucin gene and antigen expression in biliopancreatic carcinogenesis Ann. Oncol. 10 Suppl 4 1999 S51 S55
43. S.P. Langdon, and J.F. Smyth Inhibition of cell signalling pathways Cancer Treat. Rev. 21 1995 65 89
44. S. Letourneau, and N. Beauchemin Rôles des antigènes carcino-embryonnaires dans la cancérisation et la progression tumorale Med. Sci. (Paris) 13 1997 483 491
45. K.O. Lloyd, and B.W.T. Yin Synthesis and secretion of the ovarian cancer antigen CA 125 by the human cancer cell line NIH OVCAR-3 Tumor Biol 22 2001 77 82
46. J.L. Magnani, Z. Steplewski, H. Koprowski, and V. Ginsburg Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin Cancer Res. 43 1983 5489 5492
47. K.M. McDermott, P.R. Crocker, A. Harris, M.D. Burdick, Y. Hinoda, and T. Hayashi Overexpression of MUC 1 reconfigures the binding properties of tumor cells Int. J. Cancer 94 2001 783 791
48. R.P. McEver Selectin-carbohydrate interactions during inflammation and metastasis Glycoconj. J. 14 1997 585 591
49. I.F.C. McKenzie, and P.X. Xing Mucins in breast cancer: recent immunological advances Cancer Cells 2 1990 75 78
50. T. Meyer, and I.R. Hart Mechanisms of tumour metastasis Eur. J. Cancer 34 1998 214 221
51. S.D. Mikolajczyk, K.M. Marker, L.S. Milar, A. Kumar, M.S. Saedi, and J.K. Payne Truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer Cancer Res. 61 2001 6958 6963
52. H.M. Oosterkamp, L. Scheiner, M.C. Stefanova, K.O. Lloyd, and C.L. Finstad Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z) Int. J. Cancer 72 1997 87 94
53. T. Nakai, E.M. Hosono, T. Saga, Y. Watanabe, H. Sakara, and K. Imai J. Drugs effects on CA 125 antigen expression and antibody binding to cancer cells Int. J. Cancer 48 1991 463 467
54. R.A. Nunes, and L.N. Harris The HER2 extracellular domain as a prognostic and predictive factor in breast cancer Clin. Breast Cancer 3 2002 125 135
55. T.J. O'Brien, J.B. Beard, L.J. Underwood, R.A. Dennis, A.D. Santin, and L. York The CA 125 gene: an extracellular superstructure dominated by repeat sequences Tumor Biol 22 2001 348 366
56. T.J. O'Brien, J.B. Beard, L.J. Underwood, and K. Shigemasa The CA 125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure Tumor Biol. 23 2002 154 169
57. R. Okegawa, Y. Li, R.C. Pong, and J.T. Hsieh Cell adhesion proteins as tumor suppressors J. Urol. 167 2002 1836 1843
58. M.F. Pichon, K. Hacene, S. Guepratte, and R. Neumann Serum HER-2 extracellular domain (ECD) before the first metastasis in 128 breast cancer patients Clin. Lab. 50 2004 163 170
59. M.C. Price, F. Hudecz, C. O'Sullivan, R.W. Baldwin, P.M. Edwards, and S.J. Tendler Immunological and structural features of the protein core of human polymorphic epithelial mucin Mol. Immunol. 27 1990 795 802
60. D. Radisky, C. Hagios, and M.J. Bissell Tumors are unique organs defined by abnormal signalling and context Semin. Cancer Biol. 11 2001 87 95
61. J. Rak, and R.S. Erbel bFGF and tumor angiogenesis - back in the limelight? Nat. Med. 3 1997 1083 1084
62. S.A. Rosenberg Progress in human tumour immunology and Immunotherapy Nature 411 2001 380 384
63. Saghatchian M., Guepratte S., Hacene K., Neumann R., Floiras J.L., Pichon M.F. Serum HER-2 extracellular domain: relationship with clinicobiological presentation and prognostic value before and after primary treatment in 701 breast cancer patients. Int. J. Biol. Markers 2004; 19, 14-22.
64. M. Strauss, J. Luca, and J. Bartek Unrestricted cell cycling and cancer Nat. Med. 1 1995 1245 1246
65. A. Takada, K. Ohmori, T. Yoneda, K. Tlsuyuoka, A. Hasegawa, and M. Kiso Contribution of carboydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium Cancer Res. 53 1993 354 361
66. M. Thurin, and T. Kieber-Emmons SA-Lea and tumor metastasis: the old prediction and recent findings Hybrid. Hybridomics 2 2002 111 116
67. H. Tobioka, H. Isomura, Y. Kokai, and N. Sawada Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma J. Pathol. 198 2002 207 212
68. E.M. Vestergaard, H.O. Hein, H. Meyer, N. Grunnet, J. Jorgensen, and H. Wolf Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotvpes and evaluation of secretor and Lewis genotypes in caucasian population Clin. Chem. 45 1999 54 61
69. M.M. Webber, W. Bello, and D. Bello Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion Clin. Cancer Res. 1 1995 1089 1094
70. M. Yamamoto, A. Bhti, Y. Li, and D. Kufe Interaction of the DF3/MUC1 Breast carcinoma-associated antigen and β-catenin in cell adhesion J. Biol. Chem. 272 1997 12492 12494
71. B.W.T. Yin, A. Dnistrian, and K.O. Lloyd Ovarian cancer antigen CA 125 is encoded by the MUC 16 mucin gene Int. J. Cancer 98 2002 737 740
72. J.Z. Zaretsky, R. Sarid, Y. Aylon, L.A. Mittelman, D.H. Wreschner, and I. Keydar Analysis of the promoter of the MUC1 gene overexpressed in breast cancer FEBS Lett. 461 1999 189 195
73. S. Zrihan-Licht, A. Baruch, O. Elroy-Stein, I. Keydar, and D.H. Wreschner Tyrosine phosphorylation of the MUC 1 breast cancer membrane proteins. Cytokine receptor-like molecules FEBS Lett. 356 1994 130 136